DOI: 10.1055/s-00000004

Aktuelle Neurologie

Referenz

Brooks DJ, Agid Y, Eggert K. TC-INIT Study Group.
Treatment of end-of-dose wearing-off in parkinson's disease: stalevo (levodopa/carbidopa/entacapone) and levodopa/DDCI given in combination with Comtess/Comtan (entacapone) provide equivalent improvements in symptom control superior to that of traditional levodopa/DDCI treatment. 
Eur Neurol 2005; 53: 197-202  

Bibliographische Angaben herunterladen

Suchen in:
Aufrufen in: